LIWANLI Innovation Co., Ltd.
TAI: 3054.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Li-Ching Chen
- Employees
- 360
- Headquarters
- New Taipei City, Taiwan
- IPO year
- 2002
- Market cap
- NT$5.7B
- Website
- https://www.liwanli.com.tw
Loading 3054…
Loading profile data…Frequently asked questions about 3054
What does LIWANLI Innovation Co., Ltd. (3054.TW) do?
LIWANLI Innovation Co., Ltd. operates in the biomedical science industry. It provides products in the areas of nutrition and healthcare. The company offers Vigoway and powder collection products for male, female, elderly, and children audience. Its products include probiotic enzymes, pro-active nutrients, resveratrol red grape extract, algae DHA...
Where does 3054.TW trade?
LIWANLI Innovation Co., Ltd. (3054.TW) trades on the Taiwan Stock Exchange.
What sector is 3054.TW in?
LIWANLI Innovation Co., Ltd. (3054.TW) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of LIWANLI Innovation Co., Ltd.?
Li-Ching Chen is the chief executive officer of LIWANLI Innovation Co., Ltd. (3054.TW).
Where is LIWANLI Innovation Co., Ltd. headquartered?
LIWANLI Innovation Co., Ltd. is headquartered in Taiwan.
Does 3054.TW pay a dividend?
LIWANLI Innovation Co., Ltd. (3054.TW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 3054.TW go public?
LIWANLI Innovation Co., Ltd. (3054.TW) completed its initial public offering in 2002.